InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,840.00
(
1.01%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.56
(
-0.89%
)
Bitcoin
56,343.91
(
-1.12%
)
Post# of 1845
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Numbmonk

Send PM Follow Ignore
Followers 13
Posts 1554
Boards Moderated 0
Alias Born 09/27/2017

Numbmonk

Re: None

Tuesday, 04/30/2019 9:58:45 AM

Tuesday, April 30, 2019 9:58:45 AM

Post# of 1845
In March 2019, ABcann Germany received its pharmaceutical wholesale license and GDP-certificate and partnered with Australian Medical Cannabis Services on an observational study on the use of cannabinoids as therapy for chronic pain
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up